Skip to main content

Peer Review reports

From: No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects

Original Submission
18 Mar 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
7 Jun 2016 Editorially accepted
22 Jul 2016 Article published 10.1186/s12879-016-1629-5

You can find further information about peer review here.

Back to article page